Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kurt J. Hilzinger currently holds 16,534 shares of Outlook Therapeutics, Inc. (OTLK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kurt J. Hilzinger has been a net seller of OTLK stock. They have purchased $901.0K and sold $6.2M worth of shares.
Kurt J. Hilzinger's most recent insider trade was on Jun 30, 2026, when they sold 233 shares at $392.32 per share.
Kurt J. Hilzinger serves as Executive at Outlook Therapeutics, Inc. (OTLK). They have executed 60 insider transactions totaling $7.1M over their tenure at the company.
Kurt J. Hilzinger holds the position of Executive at Outlook Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Kurt J. Hilzinger has shown a selling trading pattern, with $901.0K in total purchases and $6.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kurt J. Hilzinger was on May 26, 2026, when they purchased $176.5K worth of OTLK shares. This transaction involved 400,000 shares at $0.44 per share.
Kurt J. Hilzinger currently owns 16,534 shares of Outlook Therapeutics, Inc. (OTLK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kurt J. Hilzinger's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kurt J. Hilzinger has 60 Form 4 filings on record as an insider at Outlook Therapeutics, Inc..
Set alerts for Kurt J. Hilzinger and 40,000+ other insiders.